Antioxidant Flavonoid Diosmetin Is Cardioprotective in a Rat Model of Myocardial Infarction Induced by Beta 1-Adrenergic Receptors Activation

Author:

Ahmad Taseer123ORCID,Khan Taous2,Kirabo Annet3ORCID,Shah Abdul Jabbar2

Affiliation:

1. Department of Pharmacy, Abbottabad Campus, COMSATS University Islamabad, University Road, Abbottabad 22060, Pakistan

2. Laboratory of Cardiovascular Research and Integrative Pharmacology, College of Pharmacy, University of Sargodha, University Road, Sargodha 40100, Pakistan

3. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA

Abstract

Myocardial infarction (MI) is a common and life-threatening manifestation of ischemic heart diseases (IHD). The most important risk factor for MI is hypertension. Natural products from medicinal plants have gained considerable attention globally due to their preventive and therapeutic effects. Flavonoids have been found to be efficacious in ischemic heart diseases (IHD) by alleviating oxidative stress and beta-1 adrenergic activation, but the mechanistic link is not clear. We hypothesized that antioxidant flavonoid diosmetin is cardioprotective in a rat model of MI induced by beta 1-adrenergic receptor activation. To test this hypothesis, we evaluated the cardioprotective potential of diosmetin on isoproterenol-induced MI in rats by performing lead II electrocardiography (ECG), cardiac biomarkers including troponin I (cTnI) and creatinine phosphokinase (CPK), CK-myocardial band, (CK-MB), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), and aspartate aminotranferase (AST) by using biolyzer 100, as well as histopathological analysis. We found that diosmetin (1 and 3 mg/kg) attenuated isoproterenol-induced elevation in the T-wave and deep Q-wave on the ECG, as well as heart-to-body weight ratio and infarction size. In addition, pretreatment with diosmetin attenuated the isoproterenol-induced increase in serum troponin I. These results demonstrate that flavonoid diosmetin may provide therapeutic benefit in myocardial infarction.

Funder

National Institutes of Health

Publisher

MDPI AG

Subject

Microbiology (medical),Molecular Biology,General Medicine,Microbiology

Reference73 articles.

1. Ischemic Cardiomyopathy: Pathophysiologic Mechanisms;Anversa;Prog. Cardiovasc. Dis.,1990

2. Mortality from Ischemic Heart Disease;Nowbar;Circ. Cardiovasc. Qual. Outcomes,2019

3. Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries;Gaziano;Curr. Probl. Cardiol.,2010

4. Ultrastructural Changes in the Myocardial Myocytic Mitochondria: Crucial Step in the Development of Oxygen Radical-Induced Damage in Isolated Rat Hearts?;Hegstad;Basic Res. Cardiol.,1994

5. Oxidative Stress and Ischemic Myocardial Syndromes;Misra;Med. Sci. Monit.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3